Transgender and gender-nonconforming (TGNC) youth often report higher rates of chronic social stressors such as victimization, discrimination, and rejection. Some of these gender-based stressors may have long-range physical health consequences through inflammation pathways. This study evaluates the feasibility and acceptability of adding biological measures of inflammation to an ongoing prospective clinical study of TGNC youth (ages 9–20 years), initiating affirming medical therapy at a large, urban children's hospital (N=56). We also examine the relationship between gender-based sources of stress and support with inflammation. This is the first study to explore how gender identity, social stressors, and social supports may contribute to poorer health in TGNC youth through inflammation and immune dysregulation pathways.
Methods:
Between October 2016 and August 2018, the study team collected dried blood spot (DBS) samples and health measures during clinical visits. Participants also completed computer-assisted surveys assessing gender minority stress and support during these visits. We used regression analysis to evaluate differences in C-reactive protein (CRP) controlling for demographics, health, gender-based stress, and supports.
Results:
The results from this study indicate that adding DBS samples to assess inflammation was feasible and acceptable in a clinical sample of TGNC youth seeking affirming-medical interventions. We found an association between greater inflammation and the composite score for greater gender-based stressors and lower gender-based supports using the Gender Minority Stress and Resilience Tool (GMSR); however, we did not find statistically significant differences in CRP associated with any of the individual GMSR subscales assessing various types of gender-based supports or stressors.
Conclusion:
More research is necessary to evaluate how different sources of gender-based support and stress relate to inflammation with larger sample sizes.
Get full access to this article
View all access options for this article.
References
1.
DowningJM, PrzedworskiJM. Health of transgender adults in the U.S., 2014–2016. Am J Prev Med. 2018; 55:336–344.
2.
ReisnerSL, GreytakEA, ParsonsJT, YbarraML. Gender minority social stress in adolescence: disparities in adolescent bullying and substance use by gender identity. J Sex Res. 2015; 52:243–256.
3.
KosenkoKA.Contextual influences on sexual risk-taking in the transgender community. J Sex Res. 2011; 48:285–296.
4.
de VriesALC, McGuireJK, SteensmaTD, et al.Young adult psychological outcome after puberty suppression and gender reassignment. Pediatrics. 2014; 134:696–704.
5.
CopelandWE, WolkeD, LereyaST, et al.Childhood bullying involvement predicts low-grade systemic inflammation into adulthood. Proc Natl Acad Sci. 2014; 111:7570–7575.
6.
EhrlichKB, MillerGE, RohlederN, AdamEK. Trajectories of relationship stress and inflammatory processes in adolescence. Dev Psychopathol. 2015; FirstView:1–12.
7.
McDadeTW.Early environments and the ecology of inflammation. Proc Natl Acad Sci. 2012; 109(Supplement 2):17281–17288.
8.
RobertsAL, RosarioM, SlopenN, et al.Childhood gender nonconformity, bullying victimization, and depressive symptoms across adolescence and early adulthood: an 11-year longitudinal study. J Am Acad Child Adolesc Psychiatry. 2013; 52:143–152.
9.
MeyerIH.Resilience in the study of minority stress and health of sexual and gender minorities. Psychol Sex Orientat Gend Divers. 2015; 2:209–213.
10.
White HughtoJM, ReisnerSL, PachankisJE. Transgender stigma and health: a critical review of stigma determinants, mechanisms, and interventions. Soc Sci Med. 2015; 147:222–231.
11.
SinghAA.Transgender youth of color and resilience: negotiating oppression and finding support. Sex Roles. 2013; 68:690–702.
12.
SinghAA, MengSE, HansenAW. “I Am My Own Gender”: resilience strategies of trans youth. J Couns Dev. 2014; 92:208–218.
13.
SinghAA, HaysDG, WatsonLS. Strength in the face of adversity: resilience strategies of transgender individuals. J Couns Dev. 2011; 89:20–27.
14.
BudgeSL, AdelsonJL, HowardKAS. Anxiety and depression in transgender individuals: the roles of transition status, loss, social support, and coping. J Consult Clin Psychol. 2013; 81:545–557.
15.
BarrSM, BudgeSL, AdelsonJL. Transgender community belongingness as a mediator between strength of transgender identity and well-being. J Couns Psychol. 2016; 63:87–97.
16.
BozaC, PerryKN. Gender-related victimization, perceived social support, and predictors of depression among transgender Australians. Int J Transgenderism. 2014; 15:35–52.
17.
GrossmanAH, D'augelliAR, FrankJA. Aspects of psychological resilience among transgender youth. J LGBT Youth. 2011; 8:103–115.
18.
SinghAA, HaysDG, WatsonLS. Strength in the face of adversity: resilience strategies of transgender individuals. J Couns Dev. 2011; 89:20–27.
19.
CacioppoJT, PatrickW. Loneliness: Human Nature and the Need for Social Connection. New York: W. W. Norton & Company, 2008.
20.
HouseJS, LandisKR, UmbersonD. Social relationships and health. Science. 1988; 241:540–545.
21.
LernerRM, LernerJV, AlmerigiJB, et al.Positive youth development, participation in community youth development programs, and community contributions of fifth-grade adolescents: findings from the first wave of the 4-H Study of Positive Youth Development. J Early Adolesc. 2005; 25:17–71.
22.
BocktingWO, MinerMH, Swinburne RomineRE, et al.Stigma, mental health, and resilience in an online sample of the US transgender population. Am J Public Health. 2013; 103:943–951.
23.
MossakowskiKN.Coping with perceived discrimination: does ethnic identity protect mental health?. J Health Soc Behav. 2003; 44:318–331.
24.
SegerstromSC, MillerGE. Psychological stress and the human immune system: a meta-analytic study of 30 years of inquiry. Psychol Bull. 2004; 130:601–630.
25.
MillerGE, ChenE, ParkerKJ. Psychological stress in childhood and susceptibility to the chronic diseases of aging: moving toward a model of behavioral and biological mechanisms. Psychol Bull. 2011; 137:959–997.
26.
EverettBG, RosarioM, McLaughlinKA, AustinSB. Sexual orientation and gender differences in markers of inflammation and immune functioning. Ann Behav Med. 2013; 47:57–70.
27.
McDadeTW, HawkleyLC, CacioppoJT. Psychosocial and behavioral predictors of inflammation in middle-aged and older adults: the Chicago Health, Aging, and Social Relations Study. Psychosom Med. 2006; 68:376–381.
28.
McDadeTW, LindauST, WroblewskiK. Predictors of C-reactive protein in the national social life, health, and aging project. J Gerontol B Psychol Sci Soc Sci. 2011; 66B:129–136.
29.
SapolskyRM.Why Zebras Don't Get Ulcers: The Acclaimed Guide to Stress, Stress-Related Diseases, and Coping—Now Revised and Updated. New York: Macmillan, 2004.
30.
GunnarM, QuevedoK. The neurobiology of stress and development. Annu Rev Psychol. 2007; 58:145–173.
31.
FagundesCP, WayB. Early-life stress and adult inflammation. Curr Dir Psychol Sci. 2014; 23:277–283.
32.
WatsonJ, JonesHE, BanksJ, et al.Use of multiple inflammatory marker tests in primary care: using Clinical Practice Research Datalink to evaluate accuracy. Br J Gen Pract. 2019; 69:e462–e469.
33.
StrimbuK, TavelJA. What are biomarkers?. Curr Opin HIV AIDS. 2010; 5:463–466.
34.
DuboisLZ.Associations between transition-specific stress experience, nocturnal decline in ambulatory blood pressure, and C-reactive protein levels among transgender men. Am J Hum Biol. 2012; 24:52–61.
35.
McDadeTW.Development and validation of assay protocols for use with dried blood spot samples. Am J Hum Biol. 2014; 26:1–9.
36.
ChavandukaTMD, GamarelKE, ToddKP, StephensonR. Responses to the gender minority stress and resilience scales among transgender and nonbinary youth. J LGBT Youth. 2020:1–20. DOI:10.1080/19361653.2020.1719257
37.
TestaRJ, HabarthJ, PetaJ, et al.Development of the Gender minority stress and resilience measure. Psychol Sex Orientat Gend Divers. 2015; 2:65–77.
38.
HidalgoMA, PetrasH, ChenD, ChodzenG. The Gender Minority Stress and Resilience Measure: psychometric validity of an adolescent extension. Clin Pract Pediatr Psychol. 2019; 7:278–290.
GroupWAW.The Alcohol, Smoking and Substance Involvement Screening Test (ASSIST): development, reliability and feasibility. Addiction. 2002; 97:1183–1194.
41.
McDadeTW, BurhopJ, DohnalJ. High-sensitivity enzyme immunoassay for C-reactive protein in dried blood spots. Clin Chem. 2004; 50:652–654.
42.
McDadeTW, WilliamsS, SnodgrassJJ. What a drop can do: dried blood spots as a minimally invasive method for integrating biomarkers into population-based research. Demography. 2007; 44:899–925.
43.
SteptoeA, HamerM, ChidaY. The effects of acute psychological stress on circulating inflammatory factors in humans: a review and meta-analysis. Brain Behav Immun. 2007; 21:901–912.
44.
FagundesCP, GlaserR, Kiecolt-GlaserJK. Stressful early life experiences and immune dysregulation across the lifespan. Brain Behav Immun. 2013; 27C:8–12.
45.
McDadeTW.Life history theory and the immune system: steps toward a human ecological immunology. Am J Phys Anthropol. 2003; 122(S37):100–125.
46.
MurchisonGR, AgénorM, ReisnerSL, WatsonRJ. School restroom and locker room restrictions and sexual assault risk among transgender youth. Pediatrics. 2019; 143:e20182902.
47.
RiderGN, McMorrisBJ, GowerAL, et al.Health and care utilization of transgender and gender nonconforming youth: a population-based study. Pediatrics. 2018; 141:e20171683.
48.
ToddK, PeitzmeierSM, KattariSK, et al.Demographic and behavioral profiles of nonbinary and binary transgender youth. Transgender Health. 2019; 4:254–261.
49.
AitkenM, SteensmaTD, BlanchardR, et al.Evidence for an altered sex ratio in clinic-referred adolescents with gender dysphoria. J Sex Med. 2015; 12:756–763.
50.
ChenM, FuquaJ, EugsterEA. Characteristics of referrals for gender dysphoria over a 13-year period. J Adolesc Health. 2016; 58:369–371.
51.
BureauUC. Poverty Status: POV-26. Published 2018. https://www.census.gov/data/tables/time-series/demo/income-poverty/cps-pov/pov-26.html Accessed May19, 2019.
52.
ReisnerSL, BaileyZ, SeveliusJ. Racial/ethnic disparities in history of incarceration, experiences of victimization, and associated health indicators among transgender women in the U.S. Women Health. 2014; 54:750–767.
53.
ReisnerSL, PoteatT, KeatleyJ, et al.Global health burden and needs of transgender populations: a review. Lancet. 2016; 388:412–436.
54.
GriffinJA, CasanovaTN, Eldridge-SmithED, SteplemanLM. Gender minority stress and health perceptions among transgender individuals in a small Metropolitan Southeastern Region of the United States. Transgender Health. 2019; 4:247–253.
55.
MillingtonK, SchulmeisterC, FinlaysonC, et al.Physiological and metabolic characteristics of a cohort of transgender and gender-diverse youth in the United States. J Adolesc Health. 2020. DOI: 10.1016/j.jadohealth.2020.03.028
56.
Childhood Obesity Facts | Overweight & Obesity | CDC. Published January 31, 2019. https://www.cdc.gov/obesity/data/childhood.html Accessed May19, 2019.
57.
AronsonD, BarthaP, ZinderO, et al.Obesity is the major determinant of elevated C-reactive protein in subjects with the metabolic syndrome. Int J Obes Relat Metab Disord J Int Assoc Study Obes. 2004; 28:674–679.
58.
McDadeTW, RutherfordJN, AdairL, KuzawaC. Population differences in associations between C-reactive protein concentration and adiposity: comparison of young adults in the Philippines and the United States. Am J Clin Nutr. 2009; 89:1237–1245
59.
VisserM, BouterLM, McQuillanGM, et al.Elevated C-reactive protein levels in overweight and obese adults. JAMA. 1999; 282:2131–2135.
60.
VelhoI, FigheraTM, ZiegelmannPK, SpritzerPM. Effects of testosterone therapy on BMI, blood pressure, and laboratory profile of transgender men: a systematic review. Andrology. 2017; 5:881–888.
61.
FernandezJD, TannockLR. Metabolic effects of hormone therapy in transgender patients. Endocr Pract. 2015; 22:383–388.
O'LoughlinJ, LambertM, KarpI, et al.Association between cigarette smoking and C-reactive protein in a representative, population-based sample of adolescents. Nicotine Tob Res Off J Soc Res Nicotine Tob. 2008; 10:525–532.
64.
NIMH. Major Depression. National Institute of Mental Health Depression. Published February 2018. https://www.nimh.nih.gov/health/statistics/major-depression.shtml Accessed May4, 2020.
65.
LipariR, HughesA, WilliamsM. National Surveys on Drug Use andHealth. SAMHSA, Center for Behavioral Health Statistics andQuality, 2016. https://www.samhsa.gov/data/sites/default/files/report_2385/ShortReport-2385.html Accessed May4, 2020.
66.
ChodzenG, HidalgoMA, ChenD, GarofaloR. Minority stress factors associated with depression and anxiety among transgender and gender-nonconforming youth. J Adolesc Health Off Publ Soc Adolesc Med. 2019; 64:467–471.
67.
FordES, GilesWH, MyersGL, et al.C-reactive protein concentration distribution among US children and young adults: findings from the National Health and Nutrition Examination Survey, 1999–2000. Clin Chem. 2003; 49:1353–1357.
68.
Wium-AndersenMK, ØrstedDD, NielsenSF, NordestgaardBG. Elevated C-reactive protein levels, psychological distress, and depression in 73 131 individuals. JAMA Psychiatry. 2013; 70:176–184.
69.
FordDE, ErlingerTP. Depression and C-reactive protein in US adults: data from the Third National Health and Nutrition Examination Survey. Arch Intern Med. 2004; 164:1010–1014.
70.
SterzingPR, RatliffGA, GartnerRE, et al.Social ecological correlates of polyvictimization among a national sample of transgender, genderqueer, and cisgender sexual minority adolescents. Child Abuse Negl. 2017; 67:1–12.
71.
ValentineSE, ShipherdJC. A systematic review of social stress and mental health among transgender and gender non-conforming people in the United States. Clin Psychol Rev. 2018; 66:24–38.
72.
BocktingW, ColemanE, DeutschMB, et al.Adult development and quality of life of transgender and gender nonconforming people. Curr Opin Endocrinol Diabetes Obes. 2016; 23:188–197.
73.
KattariSK, Atteberry-AshB, KinneyMK, et al.One size does not fit all: differential transgender health experiences. Soc Work Health Care. 2019; 58:899–917.
